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1. Introduction 
The pFc’ fragment* is a dimeric subunit of im- 
munoglobulin G (IgG) released from the carboxyter- 
minal end of the molecule following pepsin digestion. 
It contains about 230 amino acids, has a molecular 
weight of 26,000 and thus represents approximately 
one-half of the Fc region of IgG [4]. It has been ac- 
tively investigated for several biological [2,5,6] and 
genetic [2,7] activities known to reside in the Fc re- 
gion, but so far only limited experiments have been 
performed with IgG of different subclasses and genetic 
types. 
The genetic (Gm) markers of the ychains of the 
four subclasses of human IgG are as follows: rl chains 
from the IgG 1 subclass are either Gm (at zt) or Gm 
(ft) “non a” t [8] : 72 chains from the IgG 2 subclass 
are either Gm (nt) or (n-) and both types are, in ad- 
dition, “non a” + and “non g” + [8] : r3 chains from 
the IgG 3 subclass are either Cm@+) “non a” t or Gm 
(bt) “non a” t, “non g” t: 74 chains from the IgG 4 
subclass do not possess any of the known Gm markers. 
With the exception of Gm (z) and Gm (f) these genetic 
antigens are all present in the Fc region [8,9]. Rea- 
gens are available for testing all of the markers except 
(n-) for which no test system is known. 
Recently, we reported that pFc’ fragment prepared 
* pFc' fragment: syn. Pep III’ [ l] : Component II [ 21 stFc 
[ 31. No lntemationationally approved nomenclature exists 
at the time of writing. 
North-Holland fiblishing Company - Amsterdam 
from pooled human IgG retained both the Gm (a) and 
“non a” genetic activities [7] . There was also a weakly 
positive reaction with the Gm (b’) reagent but we 
were unable to reach any definite conclusion regard- 
ing the antigenic markers of the 72 and r3 chains. 
Furthermore, it was not established whether the “non 
a” activity was derived from each of the IgG I,2 and 3 
subclasses orwhether it originated entirely from the 
I& 1 subclass. This uncertaint;r arises because pooled 
IgG contains approximately 70% IgG 1 and only 18% 
IgG2and8%IgG3. 
We now report studies on isolated G-myeloma pro- 
teins of the IgG 1, IgG 2 and IgG 3 subclasses and the 
identification of the “non a” antigen in the pFc’ frag- 
ments of all these subclasses. In addition, the Gm (b’) 
antigen was localized in the pFc’ fragment of Gm (b) 
proteins. 
2. Materials and methods 
Human G-myeloma proteins were isolated by two- 
step procedures as follows: zoneelectrophoresis on 
Pevikon block [lo] followed by DEAE cellulose 
batch chromatography [ 1l] for IgG 1 and IgG 3 pro- 
teins; zone electrophoresis on Pevikon block followed 
by DEAEcellulose gradient chromatography for IgG 2 
proteins. The purity of isolated proteins was assessed 
by (1) immunoelectrophoresis w th a polyvalent anti- 
serum to human proteins and (2) Gm tests for con- 
taminating I G of other subclasses. When detectable, 
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Class and Protein or Genetic antigens 
designation fragment 
of protein tested 2 a f n g b” bl “non a” “non g” 
IgG lGm(f) Igc - - + - - - - + 
pFc’ fragment - - - - _ _ - + 
rprC 1 Gm (a) IE + + - - - - - - 
pFc’ fragment + - - - _ - - 
IgG 2 Gm (n-) IgG - - - - - _ - + + 
pFc’ fragment - - - - - - + 
IgG 2 Gm (n+) Igc - - - + - - - + + 
pFc’ fragment - - - - - _ - + 
IE3GmW IgG - - - _ + - - + 
pFc’ fragment - - - - - - + 
IgG3Gm@) Igc - - - - - + + + f 
pFc’ fragment - - - - - + - + 
Preparations were tested for inhibitory capacity over the concentration range 0.002-0.5 mg/ml. Positive end-points were alI within 
the range 0.002-0.015 mg/ml and negative nd points were all > 0.5 mg/ml. 
such contamination was below a level of approximate- 
ly 1%. 
The optimum conditions for the preparation of pFc’ 
fragment were determined for each subclass. Pepsin 
digestion was carried out at pH 4.5 and a temperature 
of 37°C using an enzyme: substrate ratio of 1: 100 in 
all cases. The maximum yield of pFc’ fragment was 
obtained at widely different times depending upon 
the subclass [12]. Thus for IgG 1 proteins, IO-24 hr 
of digestion was optimum; for IgG 2 proteins 6 hr was 
used and for IgG 3 proteins 1 hr digestion was suffi- 
cient. In every case enzyme action was terminated by 
adjusting the pH to 8.0 by addition of solid tris salt. 
Digested material was fractionated by gel-fdtration 
on Sephadex G-150 as previously described [7] but 
using experimental conditions giving a high order of 
resolution. Thus it was not necessary to recycle the 
pFc’ fragment on Sephadex G-50 as was the case pre- 
viously [7] because, under the present conditions, the 
fragment was well separated from the potential con- 
taminant-Fab’ fragment. 
The purity of the pFc’ fragment was established by 
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(1) a constant elution position on Sephadex G-150 gel 
filtration; (2) starch gel analysis in acid urea pH 3.0 
[12] ; (3) immunological tests using specific antisera 
and (4) the results of Gm typing. 
3. Results 
Fig. 1 shows gel filtration profiles of pepsin digested 
Gmyeloma proteins of different subclasses. Prepara- 
tions of pFc’ fragment were obtained following con- 
centration by ultrafiltration of appropriately pooled 
fractions. 
Haemagglutination-inhibition procedures [ 131 
were used to investigate preparations for the following 
activities: Gm (z), (a), (f), (n), (g), b”) and (b’). In 
addition, haemagglutination-inhibition assays of the 
recently described “non a” and “non g” markers [S] 
were also included. All preparations were tested for 
inhibitory capacity over a concentrations range of 
0.002-0.5 mg/ml and the results of the tests are shown 
in table 1. 
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IgG 1 cm(f) 
24 hr. digestion 
IgG 2 Cm(n) 
6 hr. digestion 
IgC 3 Gmk) 
1 hr. digestion 
IgG 3 Gm(b) 
1 hr. digestion 
_L 
A 0 
A l 
Fig. 1. Sephadex G-150 gel filtration profiles of pepsin digested 
human Gmyeloma proteins. In each case the digestion time em- 
ployed to give maximum yield of pFc’ fragment (0) is indicated. 
The elution position of the F(ab’)q lfragment (4 is ako shown. 
Both IgG 3 proteins produced F(ab )2 fragments having elution 
positions different from those of IgC 1 and IgG 2 F(ab )2 frag- 
ments. Possible masons for these differences are currently undes 
investigation. 
Two examples of each genetic variant were tested 
and results within groups were always consistent. In 
the IgG 1 subclass the Cm (f+) proteins gave a pFc’ 
fragment with “non a” activity whilst (a+ zt) proteins 
gave fragments with Gm(a) activity. These findings 
confirm those already published for pooled IgG [7]. 
In the IgG 2 proteins the pFc’ fragments possessed 
“non a” activity but lacked both the Gm(n) and “non 
g” antigens. Fragments prepared from IgG 3 Gm (gt) 
proteins were also “non a” positive but were Gm (g) 
negative. Finally, fragments from IgG 3 Gm (bt) pro- 
teins were “non a” positive and “non g” negative which 
was in agreement with the fmdings in the other sub- 
classes. However, these fragments were also Gm (b’) 
positive whilst lacking Gm (bl) activity. These results 
are summarized schematically in fg 2. 
4. Discussion 
Several important conclusions may be drawn from 
these fmdings. Firstly, pFc’ fragments can be prepared 
from IgG 1, IgG 2 and IgG 3 proteins. Secondly, the 
pFc’ fragments from these three subclasses are of SI- 
milar molecular size since each is eluted in the same 
position following Sephadex G-l 50 gel filtration. In 
addition, starch gel analysis [121 shows that the frag- 
ments have similar charge characteristics. Thus it seems 
that this part of the IgG molecule is very similar in all 
the major subclasses of IgG and a common feature of 
all such proteins is a peptide bond susceptible to pep 
sin digestion ear residue 332. 
Nevertheless, it remains difficult to evaluate wheth- 
er a 24hr pepsin digestion of a pool of normal IgG, as 
used previously [7] , gives rise to pFc’ fragment from 
either IgG 2 or IgG 3 molecules. Studies on isolated 
myeloma proteins how that very little or no pFc’ 
fragment from IgG 2 and IgG 3 proteins remains in- 
tact after 24 hr of digestion but the enzyme: substrate 
ratios for IgG 2 and IgG 3 molecules in a normal pool 
are very far from 1: 100. These facts justify our pre- 
vious caution and emphasize the value of studying 
isolated proteins of each subclass. 
The detection in IgG 3 pFc’ fragments of the Gm 
(b”) but not the Gm (bl) antigen is of great interest 
because it is the first indication of the possible mole- 
cular location of the b antigens. These are a group of 
factors of which only the Gm (b’) is constantly pre- 
sent in all Gm b proteins. Others, such as the Gm (bl) 
(b3) (b4) and (bs), may or may not be present in as- 
sociation with Gm (b”). 
The failure to detect Gm (n) @I) (g) and “non g” 
activities in pFc’ fragments may indicate that the 
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Fig. 2. Schematic diagram of the Fc region of six different chains showing presumed molecular segregation of genetic markers. 
The approximate locations of the Cm (a) and “non a” sites only are known. The “non a” and “non g” markers are represented as 
a- and g-respectively. Residue numbers are approximate and based on previously published work [4] and recent sequence data of 
Edebnan et al. [ 141. 
sites responsible for these activities reside in the N- 
terminal half of the Fc region (see fig. 2). Alternative 
ly these activities may require the presence of both 
halves of the Fc fragment or they may be in the pFc’ 
region but depend for their expression upon some 
feature of tertiary structure which is destroyed uring 
digestion. The latter explanation is less likely because 
(1) three other antigens (Gm (a), (b’) and “non a”) 
all survive the digestion process and produce good 
inhibition in the test systems and (2) there is good evi- 
dence that rabbit Pep III’ fragment (= pFc’ fragment) 
retains considerable t rtiary structure since it may be 
crystallized [l] . 
In our previous tudy [7] we also found b” activity 
in the smaller, related Fc’ fragment (Mol. Wt. 21,000). 
We are currently investigating this and other similar 
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fragments in the hope of further localizing some of the 
Gm (b) complex of antigens. 
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